What is the current price of CBIH?

The current price of CBIH is $0.00. Prices are updated in real time on Stocks360.

What is CBIH's price-to-earnings (PE) ratio?

CBIH's trailing twelve-month PE ratio is -0.01, based on current price and earnings per share data available on Stocks360.

What is CBIH's market capitalization?

CBIH's market capitalization is $1,744,012.00, placing it in the small-cap tier.

Cannabis Bioscience International Holdings, Inc. (CBIH)

Stock analysis · OTC · Healthcare · Drug Manufacturers - Specialty & Generic

$0.00

Market Cap

$1.74M

PE (TTM)

-0.01

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

1.41

Day Range

$0.00 – $0.00

52-wk Range

$0.00 – $0.00

Avg Volume

N/A

Volume

30.10K

Cannabis Bioscience International Holdings, Inc. (CBIH) is a publicly traded company in the Healthcare sector. Latest price: $0.00. Market cap $1.74M. Trailing PE -0.01. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-30 · $0.00 2026-10-29 · $0.00 (-70.00%)

Proprietary Signals

Signal snapshot temporarily unavailable.

About Cannabis Bioscience International Holdings, Inc.

China Infrastructure Construction Corp. delivers specialized education focusing on medical cannabis to audiences in the United States and Latin America, while also reaching a global market through its online programs. The company further extends its services to therapeutic areas, including supporting clinical trials and offering focused treatment for sleep disorders, specifically those linked to infertility, all managed through its fertility and sleep center located in Houston, Texas. Its Pharmacology University division broadens this scope by providing consulting, digital publishing, marketing, and franchising opportunities, alongside additional educational content related to medical cannabis. Founded in 2003, the organization's main operational hub is situated in Houston, Texas.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-0.01×
P/S (TTM)	14.11×
P/B	-1.19×
P/FCF (TTM)	-7.15×
EV / EBITDA	-7.08×
EV / Sales	17.39×
Earnings Yield	-29.55%
Free Cash Flow Yield	-13.98%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$2.15M
Revenue (TTM)	$123.63K
Net Income (TTM)	-$515.29K
Free Cash Flow (TTM)	-$40.05K
Net Debt	$406.05K
Working Capital	-$1.22M
Gross Margin	-0.06%
Operating Margin	-312.80%
Net Margin	-416.81%
Return on Equity	39.33%
Return on Invested Capital	36.45%